A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
Clinical trial NCT02425891 · COMPLETED
Trial details
- NCT number
- NCT02425891
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-23
- Primary completion
- 2020-04-14
- Enrollment
- 902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.